Corrigendum to “Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia” [Nanomedicine 40 (2022 Feb); 102480. doi: 10.1016/j.nano.2021.102480]
| Autor: | Salaheldin, Taher A., Godugu, Kavitha, Bharali, Dhruba J., Fujioka, Kazutoshi, Elshourbagy, Nabil, Mousa, Shaker A. |
|---|---|
| Zdroj: | In Nanomedicine: Nanotechnology, Biology, and Medicine November 2022 46 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect